These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Targeting antigen to mouse dendritic cells via Clec9A induces potent CD4 T cell responses biased toward a follicular helper phenotype. Lahoud MH; Ahmet F; Kitsoulis S; Wan SS; Vremec D; Lee CN; Phipson B; Shi W; Smyth GK; Lew AM; Kato Y; Mueller SN; Davey GM; Heath WR; Shortman K; Caminschi I J Immunol; 2011 Jul; 187(2):842-50. PubMed ID: 21677141 [TBL] [Abstract][Full Text] [Related]
3. Antibody responses initiated by Clec9A-bearing dendritic cells in normal and Batf3(-/-) mice. Caminschi I; Vremec D; Ahmet F; Lahoud MH; Villadangos JA; Murphy KM; Heath WR; Shortman K Mol Immunol; 2012 Feb; 50(1-2):9-17. PubMed ID: 22209163 [TBL] [Abstract][Full Text] [Related]
4. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Sancho D; Joffre OP; Keller AM; Rogers NC; Martínez D; Hernanz-Falcón P; Rosewell I; Reis e Sousa C Nature; 2009 Apr; 458(7240):899-903. PubMed ID: 19219027 [TBL] [Abstract][Full Text] [Related]
5. Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity. Giampazolias E; Schulz O; Lim KHJ; Rogers NC; Chakravarty P; Srinivasan N; Gordon O; Cardoso A; Buck MD; Poirier EZ; Canton J; Zelenay S; Sammicheli S; Moncaut N; Varsani-Brown S; Rosewell I; Reis e Sousa C Cell; 2021 Jul; 184(15):4016-4031.e22. PubMed ID: 34081922 [TBL] [Abstract][Full Text] [Related]
6. RNF41 regulates the damage recognition receptor Clec9A and antigen cross-presentation in mouse dendritic cells. Tullett KM; Tan PS; Park HY; Schittenhelm RB; Michael N; Li R; Policheni AN; Gruber E; Huang C; Fulcher AJ; Danne JC; Czabotar PE; Wakim LM; Mintern JD; Ramm G; Radford KJ; Caminschi I; O'Keeffe M; Villadangos JA; Wright MD; Blewitt ME; Heath WR; Shortman K; Purcell AW; Nicola NA; Zhang JG; Lahoud MH Elife; 2020 Dec; 9():. PubMed ID: 33264090 [TBL] [Abstract][Full Text] [Related]
7. Gelsolin Attenuates Neonatal Hyperoxia-Induced Inflammatory Responses to Rhinovirus Infection and Preserves Alveolarization. Cui TX; Brady AE; Zhang YJ; Fulton CT; Popova AP Front Immunol; 2022; 13():792716. PubMed ID: 35173718 [TBL] [Abstract][Full Text] [Related]
8. DNGR-1(+) dendritic cells are located in meningeal membrane and choroid plexus of the noninjured brain. Quintana E; Fernández A; Velasco P; de Andrés B; Liste I; Sancho D; Gaspar ML; Cano E Glia; 2015 Dec; 63(12):2231-48. PubMed ID: 26184558 [TBL] [Abstract][Full Text] [Related]
9. Enhancing immune responses by targeting antigen to DC. Caminschi I; Lahoud MH; Shortman K Eur J Immunol; 2009 Apr; 39(4):931-8. PubMed ID: 19197943 [TBL] [Abstract][Full Text] [Related]
10. F-actin is an evolutionarily conserved damage-associated molecular pattern recognized by DNGR-1, a receptor for dead cells. Ahrens S; Zelenay S; Sancho D; Hanč P; Kjær S; Feest C; Fletcher G; Durkin C; Postigo A; Skehel M; Batista F; Thompson B; Way M; Reis e Sousa C; Schulz O Immunity; 2012 Apr; 36(4):635-45. PubMed ID: 22483800 [TBL] [Abstract][Full Text] [Related]
11. A novel peptide targeting Clec9a on dendritic cell for cancer immunotherapy. Yan Z; Wu Y; Du J; Li G; Wang S; Cao W; Zhou X; Wu C; Zhang D; Jing X; Li Y; Wang H; Gao Y; Qi Y Oncotarget; 2016 Jun; 7(26):40437-40450. PubMed ID: 27250027 [TBL] [Abstract][Full Text] [Related]
15. BDCA3(+)CLEC9A(+) human dendritic cell function and development. van der Aa E; van Montfoort N; Woltman AM Semin Cell Dev Biol; 2015 May; 41():39-48. PubMed ID: 24910448 [TBL] [Abstract][Full Text] [Related]
16. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Caminschi I; Proietto AI; Ahmet F; Kitsoulis S; Shin Teh J; Lo JC; Rizzitelli A; Wu L; Vremec D; van Dommelen SL; Campbell IK; Maraskovsky E; Braley H; Davey GM; Mottram P; van de Velde N; Jensen K; Lew AM; Wright MD; Heath WR; Shortman K; Lahoud MH Blood; 2008 Oct; 112(8):3264-73. PubMed ID: 18669894 [TBL] [Abstract][Full Text] [Related]
17. Cutting edge: Clec9A+ dendritic cells mediate the development of experimental cerebral malaria. Piva L; Tetlak P; Claser C; Karjalainen K; Renia L; Ruedl C J Immunol; 2012 Aug; 189(3):1128-32. PubMed ID: 22732587 [TBL] [Abstract][Full Text] [Related]
18. Mevalonate Blockade in Cancer Cells Triggers CLEC9A Xu F; Wang Z; Zhang H; Chen J; Wang X; Cui L; Xie C; Li M; Wang F; Zhou P; Liu J; Huang P; Xia X; Xia X Cancer Res; 2021 Sep; 81(17):4514-4528. PubMed ID: 34266895 [TBL] [Abstract][Full Text] [Related]